Journey Medical (DERM) Other Accumulated Expenses (2020 - 2026)
Journey Medical's (DERM) quarterly Other Accumulated Expenses came in at $472000.0 in Q1 2026, down 66.43% YoY from $1.4 million in Q1 2025, and down 73.85% on a QoQ basis from $1.8 million in Q4 2025.
Journey Medical (DERM) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Other Accumulated Expenses data on file, last reported at $472000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 66.43% year-over-year to $472000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $472000.0 (down 66.43% YoY) and the FY2025 annual result came in at $1.8 million, up 302.9% from the prior year.
- Other Accumulated Expenses declined to $472000.0 in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $3.8 million in Q1 2022 to a low of $195000.0 in Q4 2023.
- A 5-year average of $1.2 million and a median of $755000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses tumbled 89.23% — and 2025, when it soared 302.9%.
- Tracing DERM's Other Accumulated Expenses over 5 years: stood at $413000.0 in 2022, then plunged by 52.78% to $195000.0 in 2023, then soared by 129.74% to $448000.0 in 2024, then soared by 302.9% to $1.8 million in 2025, then plunged by 73.85% to $472000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $472000.0 (Q1 2026), $1.8 million (Q4 2025), and $755000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Journey Medical | 207.30 Mn | 181.66 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.07 Mn |
| Mar 31, 2026 | 472,000.00 |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 448,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 636,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 678,000.00 |
| Dec 31, 2022 | 413,000.00 |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 3.03 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 4.50 Mn |